These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 24331748

  • 1. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
    Adefuye PO, Broutet NJ, de Sanjosé S, Denny LA.
    Vaccine; 2013 Dec 29; 31 Suppl 5():F53-9. PubMed ID: 24331748
    [Abstract] [Full Text] [Related]

  • 2. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R, Anorlu R, Sangwa-Lugoma G, Denny LA.
    Vaccine; 2013 Dec 29; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [Abstract] [Full Text] [Related]

  • 3. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ, Campos NG, O'Shea M, Diaz M, Mutyaba I.
    Vaccine; 2013 Dec 29; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [Abstract] [Full Text] [Related]

  • 4. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, Podzolkova NM, Shipulina OY, Sultanov SN, Kosenko IA, Brotons M, Buttmann N, Dartell M, Arbyn M, Syrjänen S, Poljak M.
    Vaccine; 2013 Dec 31; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J, Bogaards JA, Demirel E, Diaz M, Sharma M, Kim JJ.
    Vaccine; 2013 Dec 31; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [Abstract] [Full Text] [Related]

  • 6. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J.
    Vaccine; 2012 Nov 20; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [Abstract] [Full Text] [Related]

  • 7. Overview of cervical cancer screening practices in the extended Middle East and North Africa countries.
    Sancho-Garnier H, Khazraji YC, Cherif MH, Mahnane A, Hsairi M, El Shalakamy A, Osgul N, Tuncer M, Jumaan AO, Seoud M.
    Vaccine; 2013 Dec 30; 31 Suppl 6():G51-7. PubMed ID: 24331820
    [Abstract] [Full Text] [Related]

  • 8. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ, Sharma M, O'Shea M, Sweet S, Diaz M, Sancho-Garnier H, Seoud M.
    Vaccine; 2013 Dec 30; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [Abstract] [Full Text] [Related]

  • 9. Upgrading public health programs for human papillomavirus prevention and control is possible in low- and middle-income countries.
    Steben M, Jeronimo J, Wittet S, Lamontagne DS, Ogilvie G, Jensen C, Smith J, Franceschi S.
    Vaccine; 2012 Nov 20; 30 Suppl 5():F183-91. PubMed ID: 23199962
    [Abstract] [Full Text] [Related]

  • 10. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
    De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP.
    Vaccine; 2013 Dec 29; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
    [Abstract] [Full Text] [Related]

  • 11. Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review.
    Elfström KM, Herweijer E, Sundström K, Arnheim-Dahlström L.
    Curr Opin Oncol; 2014 Jan 29; 26(1):120-9. PubMed ID: 24248011
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R, Bhatla N, Gravitt PE, Basu P, Esmy PO, Ashrafunnessa KS, Ariyaratne Y, Shah A, Nene BM.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [Abstract] [Full Text] [Related]

  • 13. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
    Kohl I.
    Klin Mikrobiol Infekc Lek; 2006 Jun 19; 12(3):91-7. PubMed ID: 17051469
    [Abstract] [Full Text] [Related]

  • 14. Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.
    Bosch FX, Tsu V, Vorsters A, Van Damme P, Kane MA.
    Vaccine; 2012 Nov 20; 30 Suppl 5():F1-11. PubMed ID: 23199951
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M.
    Clin Microbiol Infect; 2012 Oct 20; 18 Suppl 5():64-9. PubMed ID: 22862799
    [Abstract] [Full Text] [Related]

  • 16. Prevention of cervical cancer in Africa: a daunting task?
    Walraven G.
    Afr J Reprod Health; 2003 Aug 20; 7(2):7-12. PubMed ID: 14677294
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.
    Louie KS, de Sanjose S, Mayaud P.
    Trop Med Int Health; 2009 Oct 20; 14(10):1287-302. PubMed ID: 19772550
    [Abstract] [Full Text] [Related]

  • 18. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies.
    Fokom-Domgue J, Combescure C, Fokom-Defo V, Tebeu PM, Vassilakos P, Kengne AP, Petignat P.
    BMJ; 2015 Jul 03; 351():h3084. PubMed ID: 26142020
    [Abstract] [Full Text] [Related]

  • 19. Cost-utility analysis of interventions to reduce the burden of cervical cancer in Israel.
    Ginsberg GM.
    Vaccine; 2013 Nov 22; 31 Suppl 8():I46-52. PubMed ID: 24229719
    [Abstract] [Full Text] [Related]

  • 20. Cervical cancer screening, human papillomavirus vaccination practices and current infrastructure in Israel.
    Schejter E, Bornstein J, Siegler E.
    Vaccine; 2013 Nov 22; 31 Suppl 8():I42-5. PubMed ID: 24229718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.